BOGOCH, Samuel,BOGOCH, Elenore S.,BORSANYI, Anne-Elenore Bogoch,BOGOCH, Samuel Winston
申请号：
USUS2014/060906
公开号：
WO2015/057966A3
申请日:
2014.10.16
申请国别(地区):
WO
年份:
2015
代理人:
摘要：
The present invention provides an isolated or synthesized protein fragment or peptide comprising at least one peptide sequence that is at least 50% homologous with at least one Replikin peptide sequence identified in a MERS CoV. The at least one peptide sequence may be at least 80% homologous with at least one Replikin peptide sequence identified in a MERS CoV. The at least one peptide sequence may be at least 46% homologous with at least one Replikin peptide sequence identified in a MERS CoV. The at least one peptide sequence may be at least 53% homologous with at least one Replikin peptide sequence.La présente invention concerne des thérapies, des vaccins et des procédés prédictifs pour les coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) et des composés pour le diagnostic, la prévention et le traitement déclosions de MERS-CoV.
